Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × perflutren × Clear all

NCT01062178 2016-03-08

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

Phase 2 Completed

Carcinoma, Renal Cell